PRTN3 and arthritic joint disease: Following the original study by van de Stadt et al., the Amsterdam group evaluated a new cohort of 163 seropositive patients (ACPA negative/RF positive 44%; ACPA positive/RF negative 27%; ACPA positive/RF positive 29%) with arthralgia but without clinical arthritis [30].